GTF2I acts as a novel tumor suppressor transcription factor and shows Favorable prognosis in renal cancer.

IF 1.5 4区 生物学 Q4 CELL BIOLOGY Integrative Biology Pub Date : 2025-01-08 DOI:10.1093/intbio/zyaf001
Tikam Chand Dakal, Mony Thakur, Nancy George, Tiratha Raj Singh, Vinod Yadav, Abhishek Kumar
{"title":"GTF2I acts as a novel tumor suppressor transcription factor and shows Favorable prognosis in renal cancer.","authors":"Tikam Chand Dakal, Mony Thakur, Nancy George, Tiratha Raj Singh, Vinod Yadav, Abhishek Kumar","doi":"10.1093/intbio/zyaf001","DOIUrl":null,"url":null,"abstract":"<p><p>The role of GTF2I (General Transcription Factor2I) alteration has already been reported in thymic cancer as a valuable biomarker. However, the association of GTF2I mutation with renal cancer for prognosis of immunotherapy is not yet examined. The biologic and oncologic significance of GTF2I in renal cancer was examined at multiomics level such as mutation, copy number alteration, structural variants. The Cancer Genome Atlas (TCGA), Human Protein Atlas (HPA) were used to retrieve the omics data. The expression of GTF2I mRNA was quite significant in case of renal caner. Correlation among the GTF2I mRNA, mutation, CNA and structural variants was also studied. Interactome of GTF2I was also constructed using STRING database. Gain, amplification, and missense mutation exhibited a positive correlation between GTF2I mRNA expression and non-structural variants. Similarly, GTF2I mRNA expression and copy number alterations from GISTIC were positively correlated. High expression of GTF2I was associated with better overall survival indicating the less aggressive clinical features. Insight Box Investigating GTF2I's complex function as a tumor suppressor transcription factor in renal carcinoma provides fresh insights into its biologic and oncologic importance, especially when considering the prognosis of immunotherapy. Little is known about its possible use as a biomarker for renal cancer. Using a multiomics approach and utilizing information from the Human Protein Atlas (HPA) and The Cancer Genome Atlas (TCGA), our study clarifies the intricate relationship between mRNA expression, GTF2I changes, and clinical outcomes in renal cancer. Our results indicate that GTF2I expression may be used as a prognostic indicator because it is positively correlated with favorable survival outcomes. Furthermore, the molecular interactions behind GTF2I's functional significance in renal cancer are revealed by interactome analysis utilizing the STRING database, providing important information for further study and treatment approaches.</p>","PeriodicalId":80,"journal":{"name":"Integrative Biology","volume":"17 ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Integrative Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1093/intbio/zyaf001","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The role of GTF2I (General Transcription Factor2I) alteration has already been reported in thymic cancer as a valuable biomarker. However, the association of GTF2I mutation with renal cancer for prognosis of immunotherapy is not yet examined. The biologic and oncologic significance of GTF2I in renal cancer was examined at multiomics level such as mutation, copy number alteration, structural variants. The Cancer Genome Atlas (TCGA), Human Protein Atlas (HPA) were used to retrieve the omics data. The expression of GTF2I mRNA was quite significant in case of renal caner. Correlation among the GTF2I mRNA, mutation, CNA and structural variants was also studied. Interactome of GTF2I was also constructed using STRING database. Gain, amplification, and missense mutation exhibited a positive correlation between GTF2I mRNA expression and non-structural variants. Similarly, GTF2I mRNA expression and copy number alterations from GISTIC were positively correlated. High expression of GTF2I was associated with better overall survival indicating the less aggressive clinical features. Insight Box Investigating GTF2I's complex function as a tumor suppressor transcription factor in renal carcinoma provides fresh insights into its biologic and oncologic importance, especially when considering the prognosis of immunotherapy. Little is known about its possible use as a biomarker for renal cancer. Using a multiomics approach and utilizing information from the Human Protein Atlas (HPA) and The Cancer Genome Atlas (TCGA), our study clarifies the intricate relationship between mRNA expression, GTF2I changes, and clinical outcomes in renal cancer. Our results indicate that GTF2I expression may be used as a prognostic indicator because it is positively correlated with favorable survival outcomes. Furthermore, the molecular interactions behind GTF2I's functional significance in renal cancer are revealed by interactome analysis utilizing the STRING database, providing important information for further study and treatment approaches.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
GTF2I是一种新型的肿瘤抑制转录因子,在肾癌中具有良好的预后。
GTF2I(一般转录因子2i)改变在胸腺癌中的作用已经被报道为一种有价值的生物标志物。然而,GTF2I突变与肾癌免疫治疗预后的关系尚未得到研究。从基因突变、拷贝数改变、结构变异等多组学水平探讨GTF2I在肾癌中的生物学和肿瘤学意义。使用癌症基因组图谱(TCGA)、人类蛋白质图谱(HPA)检索组学数据。GTF2I mRNA在肾癌中的表达非常显著。研究了GTF2I mRNA、突变、CNA和结构变异之间的相关性。利用STRING数据库构建了GTF2I的交互组。增益、扩增和错义突变与GTF2I mRNA表达与非结构性变异呈正相关。同样,GTF2I mRNA的表达与GISTIC的拷贝数变化呈正相关。GTF2I的高表达与较好的总生存率相关,表明临床特征较少侵袭性。研究肾癌中GTF2I复合物作为肿瘤抑制转录因子的功能,为其生物学和肿瘤学重要性提供了新的见解,特别是在考虑免疫治疗的预后时。对于其作为肾癌生物标志物的可能用途知之甚少。采用多组学方法,利用人类蛋白质图谱(HPA)和癌症基因组图谱(TCGA)的信息,我们的研究阐明了肾癌mRNA表达、GTF2I变化与临床结局之间的复杂关系。我们的研究结果表明,GTF2I表达可作为预后指标,因为它与有利的生存结果呈正相关。此外,利用STRING数据库的相互作用组分析揭示了GTF2I在肾癌中功能意义背后的分子相互作用,为进一步研究和治疗方法提供了重要信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Integrative Biology
Integrative Biology 生物-细胞生物学
CiteScore
4.90
自引率
0.00%
发文量
15
审稿时长
1 months
期刊介绍: Integrative Biology publishes original biological research based on innovative experimental and theoretical methodologies that answer biological questions. The journal is multi- and inter-disciplinary, calling upon expertise and technologies from the physical sciences, engineering, computation, imaging, and mathematics to address critical questions in biological systems. Research using experimental or computational quantitative technologies to characterise biological systems at the molecular, cellular, tissue and population levels is welcomed. Of particular interest are submissions contributing to quantitative understanding of how component properties at one level in the dimensional scale (nano to micro) determine system behaviour at a higher level of complexity. Studies of synthetic systems, whether used to elucidate fundamental principles of biological function or as the basis for novel applications are also of interest.
期刊最新文献
GTF2I acts as a novel tumor suppressor transcription factor and shows Favorable prognosis in renal cancer. Role of RGD-binding Integrins in ovarian cancer progression, metastasis and response to therapy. Identification of CXCR4 inhibitory activity in natural compounds using cheminformatics-guided machine learning algorithms. Screening of cytokines-cytokine receptor-associated genes in childhood asthma based on bioinformatics. Modeling Shiga toxin-induced human renal-specific microvascular injury.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1